BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23561982)

  • 61. Caudate atrophy and impaired frontostriatal connections are linked to executive dysfunction in temporal lobe epilepsy.
    Riley JD; Moore S; Cramer SC; Lin JJ
    Epilepsy Behav; 2011 May; 21(1):80-7. PubMed ID: 21507730
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Slowing of reaction time in Parkinson's disease: the involvement of the frontal lobes.
    Berry EL; Nicolson RI; Foster JK; Behrmann M; Sagar HJ
    Neuropsychologia; 1999 Jun; 37(7):787-95. PubMed ID: 10408646
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mid-frontal theta activity is diminished during cognitive control in Parkinson's disease.
    Singh A; Richardson SP; Narayanan N; Cavanagh JF
    Neuropsychologia; 2018 Aug; 117():113-122. PubMed ID: 29802866
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson's disease.
    Nocera JR; Price C; Fernandez HH; Amano S; Vallabhajosula S; Okun MS; Hwynn N; Hass CJ
    Parkinsonism Relat Disord; 2010 Nov; 16(9):590-4. PubMed ID: 20829093
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction.
    Malapani C; Pillon B; Dubois B; Agid Y
    Neurology; 1994 Feb; 44(2):319-26. PubMed ID: 8309583
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging.
    Ray N; Strafella AP
    Clin EEG Neurosci; 2010 Apr; 41(2):87-93. PubMed ID: 20521491
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.
    Narayanan NS; Rodnitzky RL; Uc EY
    Rev Neurosci; 2013; 24(3):267-78. PubMed ID: 23729617
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cognitive and motor dysfunction in Parkinson's disease. Clinical, performance, and computed tomographic correlations.
    Lichter DG; Corbett AJ; Fitzgibbon GM; Davidson OR; Hope JK; Goddard GV; Sharples KJ; Pollock M
    Arch Neurol; 1988 Aug; 45(8):854-60. PubMed ID: 3293555
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gait speed in Parkinson disease correlates with cholinergic degeneration.
    Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Müller ML
    Neurology; 2013 Oct; 81(18):1611-6. PubMed ID: 24078735
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced frontal function in Parkinson's disease.
    Cools R; Miyakawa A; Sheridan M; D'Esposito M
    Brain; 2010 Jan; 133(Pt 1):225-33. PubMed ID: 19995871
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dopamine, fronto-striato-thalamic circuits and risk for psychosis.
    Dandash O; Pantelis C; Fornito A
    Schizophr Res; 2017 Feb; 180():48-57. PubMed ID: 27595552
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Compensatory neural mechanisms in cognitively unimpaired Parkinson disease.
    Poston KL; YorkWilliams S; Zhang K; Cai W; Everling D; Tayim FM; Llanes S; Menon V
    Ann Neurol; 2016 Mar; 79(3):448-63. PubMed ID: 26696272
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Striatal Blood-Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study.
    Pineda-Pardo JA; Gasca-Salas C; Fernández-Rodríguez B; Rodríguez-Rojas R; Del Álamo M; Obeso I; Hernández-Fernández F; Trompeta C; Martínez-Fernández R; Matarazzo M; Mata-Marín D; Guida P; Duque A; Albillo D; Plaza de Las Heras I; Montero JI; Foffani G; Toltsis G; Rachmilevitch I; Blesa J; Obeso JA
    Mov Disord; 2022 Oct; 37(10):2057-2065. PubMed ID: 35765711
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cognitive deficits in Parkinson's disease.
    Dubois B; Pillon B
    J Neurol; 1997 Jan; 244(1):2-8. PubMed ID: 9007738
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Limbic cortical injury sustained during adulthood leads to schizophrenia-like syndrome.
    Jaskiw GE; Kenny JF
    Schizophr Res; 2002 Dec; 58(2-3):205-12. PubMed ID: 12409160
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Executive function in Parkinson's disease: contributions of the dorsal frontostriatal pathways to action and motivation.
    Ravizza SM; Goudreau J; Delgado MR; Ruiz S
    Cogn Affect Behav Neurosci; 2012 Mar; 12(1):193-206. PubMed ID: 22006555
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Perseveration and choice in Parkinson's disease: the impact of progressive frontostriatal dysfunction on action decisions.
    Hughes LE; Altena E; Barker RA; Rowe JB
    Cereb Cortex; 2013 Jul; 23(7):1572-81. PubMed ID: 22661404
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Response monitoring in de novo patients with Parkinson's disease.
    Willemssen R; Müller T; Schwarz M; Falkenstein M; Beste C
    PLoS One; 2009; 4(3):e4898. PubMed ID: 19325909
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Longitudinal assessment of social cognition in de novo Parkinson's disease patients and its relationship with dopaminergic innervation.
    Trompeta C; Gasca-Salas C; Pineda-Pardo JA; Guida P; Cohn M; Mata-Marín D; Monje MH; López-Aguirre M; Obeso I; Sánchez Ferro Á
    Behav Brain Res; 2023 Oct; 454():114654. PubMed ID: 37659457
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Contribution of frontostriatal function to sequence learning in Parkinson's disease: evidence for dissociable systems.
    Dominey PF; Jeannerod M
    Neuroreport; 1997 Mar; 8(5):iii-ix. PubMed ID: 9175085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.